Does Chromium Body Composition Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Chromium Body Composition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Insulin sensitivity improved significantly, with a 28% greater improvement in the active group than in the placebo group (adjusted geometric mean ratio 1.28; 95% confidence interval 1.14 to 1.44). [Xenos K (2026); evidence level 2] - Conclusions The fixed-dose combination improved BIA-derived body-composition measures and OGTT-derived insulin sensitivity over 12 weeks compared with placebo. [Xenos K (2026); evidence level 2] - Objectives To evaluate the efficacy of a fixed-dose combination of berberine, white mulberry leaf extract, and chromium picolinate on body weight, body composition, and insulin sensitivity in Greek adults with obesity. [Xenos K (2026); evidence level 2] - Research methodology/design This was a 12-week, randomized, double-blind, placebo-controlled trial. [Xenos K (2026); evidence level 2] - In patients with PMDD, lower γ-aminobutyric acid (GABAA) receptor δ-subunit expression and higher serotonin binding to the serotonin transporter are found in the luteal phase compared with controls, correlated with altered emotional generation through heightened amygdala activation and worse depressive symptoms, respectively [,]. [Smith Marleigh (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.